I got my degree in Medicine 1n 1989, at the University of Rome “La Sapienza”. Following my degree, I specialized in Oncology in 1994 at the University of Rome “Tor Vergata”. In the same University, I specialized in Microbiology and Virology in 2001.
I spent a period of research at the National Institute of Health, MD, USA, where I worked in the laboratory of Genetic Disorders of Drug Metabolism, Heritable Disorders Branch, National Institute of Child Health and Human Development.
Since 2002, I work in the laboratory of molecular virology of the Polyclinic Tor Vergata Foundation, Rome, Italy.
) Department of Laboratory Medicine Polyclinic Tor Vergata Foundation Rome Italy
Dr. A. Cid Arregui obtained his doctorate in Medicine (MD) and Molecular Biology (PhD) at the Autonomous University of Madrid and the European Molecular Biology Laboratory in Heidelberg. Dr. Arregui has more than 20 years of research experience in the field of cancer associated with human Papillomaviruses. Dr. Arregui is currently a group leader in the Tumor Immunology department of the German Cancer Research Center in Heidelberg, Germany.
) Translational Immunology German Cancer Research Center (DKFZ) Heidelberg Germany
Dr. Nafees Ahmad is Professor of Immunobiology and Director of Immunity and Infection at the College of Medicine, University of Arizona in Tucson, Arizona. He obtained his undergraduate and postgraduate education from the Aligarh Muslim University, India and doctorate from the Central Drug Research Institute, Lucknow and Aligarh Muslim University, India. He completed his postdoctoral fellowship in HIV/AIDS from the National Institutes of Health, Bethesda, Maryland, USA. His research has focused on mechanisms of HIV immunopathogenesis in younger and older HIV-infected patients, including the aging of the immune system. We are investigating the mechanisms of differential HIV-1 infection in younger and older populations, including the role of viral and host factors and dysregulation of T cell functions. These viral, host and immune factors may be targeted for developing new strategies for treatment and prevention of HIV infection.
) Department of Immunobiology The University of Arizona Health Sciences Center Tucson, AZ USA
Andrea Cara (PhD) is a Researcher at the Istituto Superiore di Sanità in Rome, Italy, and holds a Research Scholar position in the Department of Medicine at Duke University in Durham, NC, USA. During his career, he spent seven years at the National Institute of Health in Bethesda, MD, and three years at the Mount Sinai School of Medicine in New York. He has authored more than 80 manuscripts.
) Department of Drug Research and Evaluation Istituto Superiore di Sanita Roma Italy
Mario (Mago) Clerici graduated from medical school at the University of Milano and trained for more than 6 years at the NIH in Bethesda; in the meantime he received a PhD in internal medicine. He became an associate professor of Immunology at the University of Milano in 1993 and was promoted to full professor in 1999. Since 2009 he coordinates the research of the Don Gnocchi Foundation, and since 2008 he directs the PhD School in Molecular and Translational Medicine at the University of Milano. He authored more than 500 papers (>30,000 citations; H index=80), has been awarded National and International prizes, is a knight of the Italian Republic, and an ISI highly cited scientist (http://www.highlycited.com).
) Department of Molecular Medicine and Imaging in Rehabilitation University of Milano Milano Italy
Maria Grazia Cusi is Associate Professor in Microbiology and Virology and Chairman of the Teaching Committee for Medical Biotechnologies at the University of Siena. Since 2015 she has been the Microbiology and Virology Laboratory Director at the “S. Maria delle Scotte” Hospital of Siena. She has 30 years of experience in the research on viral vaccines against infectious diseases. Moreover, she has dedicated herself to the immunotherapy and prevention of some human tumors, first in transgenic mice, then in cancer patients. Notably, prof. Cusi has authored more than 100 manuscripts and 7 patents.
) Department of Molecular Biology, Microbiology Section Policlinico S. Maria alle Scotte V.le Bracci Siena Italy
I was trained in Molecular Virology in Paris VI University. I have been conducting research projects in the field of Human Papillomaviruses, focusing on the roles of the E2 regulatory protein in HPV infection. I then developed comparative interactomic strategies, to map E2-host interactions contributing to viral pathogenicity. Since 2013, I am applying comparative interactomics approaches to Influenza A viruses, focusing on the Influenza virus RNA-dependent RNA polymerase of low to high virulence strains. My current research topics address the interplay of the viral polymerase with the host Ubiquitin Proteasome System (UPS).
) Department of Virology Pasteur Institute Paris cedex France
Dr. Louis Flamand, Ph.D., M.B.A., is Full Professor and Vice-Chair of the Microbiology, Infectious Disease and Immunology Department at the Faculty of Medicine, Université Laval, Quebec, Canada, and Senior Researcher in the Infectious and Immune Disease Division at the CHU de Quebec Research Center. Since 2008, he is President of the Biohazards Risk Committee at Université Laval. For the past 25 years, this fundamentalist researcher actively studies various aspects of HHV-6 biology and pathogenesis. His current interest lies in the biology of inherited chromosomally-integrated HHV-6 (ciHHV-6) with emphasis on viral integration mechanisms and medical consequences associated with ciHHV-6. He is the author of more than 80 peer-reviewed publications.
) Department of Infectious and Immune Diseases Centre Hospitalier de l'Université Laval (CHUL) Ville de Québec, QC Canada
Prof. Huleihel is a senior lecturer and scientist in the Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel. He has over 30 years of experience in scientific research and discovery in the fields of virology and molecular biology. He has published more than 130 scientific publications and is a named inventor of 3 issued patents. His studies focused on examining antiviral activities of natural products and other molecular aspects of different viruses including herpes viruses and retroviruses.
) Department of Virology and Developmental Genetics Ben-Gurion University of the Negev Beer-Sheva Israel
Professor at Indian Institute of Science, Bangalore, India. Areas of research encompass epidemiology, molecular biology, vaccines and diagnostics, and molecular mechanisms of pathogenesis of rotavirus and enteroviruses. Scientific contributions include isolation of novel human-bovine reassortant rotaviruses and development of a live attenuated rotavirus vaccine candidate, determination of the new pentameric structure of rotavirus enterotoxin NSP4, and its function; analysis of nonpolio enteroviruses in acute flaccid paralysis, the first conclusive demonstration of association of non-polio enteroviruses with acute and persistent diarrhea in children, development of a newborn mouse model for enterovirus diarrhea, and enterovirus association with non-diarrheal Increased frequency of bowel movements (IFoBM-ND).
) Department of Microbiology & Cell Biology Indian Institute of Science Bangalore India
Prof. Laurent Andréoletti obtained his Doctor of Philosophy degree (1994) in Medicine from the University of Lille, France. He is currently Head of the Virology Unit and EA4684 Cardiovir research team at Centre Hospitalier Universitaire de Reims, Reims, France. His skills and expertise mainly lie in the subject areas of PCR, Cell Culture, DNA, RNA, Sequencing, Microbiology, Immunology of Infectious Diseases, HIV, Antibodies, Real-Time PCR, Viral Infection, Virology, and Vaccination. Prof. Andréoletti has authored/co-authored over 125 article publications, having a significant number of total citations, i.e. more than 2,240.
) Department of Virology University Champagne-Ardenne Reims France
Dr. Ayyavoo, Velpandi obtained her M.S. in Zoology (1983) and Ph.D. in Microbiology (1991) from Madurai Kamaraj University, Madurai, India. Her post-doctoral study was in the field of Molecular Virology from Wistar Institute and University of Pennsylvania, Philadelphia, PA. Currently, she is Professor of Infectious Diseases & Microbiology in University of Pittsburgh, PA and also an Associate Dean for Faculty Affairs, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA. Dr. Ayyavoo has received numerous honors and awards for her scientific contributions over the years. She has published more then 65 scientific publications in the field of molecular virology.
) Department of Infectious Diseases & Microbiology University of Pittsburgh Pittsburgh, PA USA
Dr. Lindsay W. Black was trained as a biochemist-molecular biologist as a graduate student in the laboratory of David Hogness (then working on lambda phage) in the biochemistry department of Arthur Kornberg in the Stanford Medical School, Stanford, CA, USA. She has maintained her interest in the prokaryotic problems that she was introduced to in both of the eminent training centers where she completed her training (Stanford Medical School and University of Geneva). Her research program has been supported for over 30 years by NIH, and, during this period, she has received an NIH Merit Award. Dr. Black is currently working in the Department of Biochemistry and Molecular Biology at University of Maryland Medical School, Baltimore, MD, USA.
) Department of Biochemistry and Molecular Biology University of Maryland Medical School Baltimore, MD USA
Dr. Shiu-Wan Chan, Ph.D., is currently a lecturer in the Faculty of Life Sciences, affiliated with the Microbiology research group, at The University of Manchester, UK. After obtaining her Ph.D. in Molecular Biology at Edinburgh, she started her post-doctorate (also in Edinburgh) on pioneering hepatitis C virus (HCV) research and has made a major breakthrough in the discovery of a new genotype of the virus, its association with false negative blood donations and in the establishment of the current phylogenetic classification of the virus. Dr. Chan, as an author/co-author, has published more than 25 articles in various journals, having a noteworthy number of total citations, i.e. over 4,665.
) Department of Biomolecular Sciences University of Manchester Manchester UK
Dr. Juan Carlos de la Torre, Ph.D., is a Professor in the Department of Immunology and Microbial Science at The Scripps Research Institute, La Jolla, CA, USA. His laboratory pioneered the development of arenavirus reverse genetics, which has provided investigators with a novel and powerful approach for the investigation of arenavirus replication, gene expression, assembly, budding and virus-host cell factor interactions that determine the infection outcome. Dr. De La Torre, as an author/co-author, has published more than 205 articles in various journals, having a very noteworthy number of total citations, i.e. over 9,185.
) Department of Neuropharmacology Scripps Research Institute La Jolla, CA USA
Dr. Karim Essani obtained his Ph.D. from the University of Western Ontario, London, ON, Canada. He is a Professor of Biological Sciences at Western Michigan University, Kalamazoo, MI, USA, where he is interested in molecular virology and immunology. He joined Western Michigan University in 1989. Dr. Essani uses tanapoxvirus and frog virus 3 as model systems to answer fundamental biological questions. He is presently interested is developing tanapoxvirus as an oncolytic virus for the immuno-oncolytic virotherapy of cancer. He, as an author/co-author, has published more than 40 articles in various journals, having total number of citations of over 770.
) Department of Biological Sciences Western Michigan University Kalamazoo, MI USA
Dr. Hiroyuki Gatanaga, M.D., Ph.D., currently works in the Department of Outpatient AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan. Dr. Gatanaga is also a Visiting Professor in the Center for AIDS Research at Kumamoto University, Kumamoto, Japan. His major research interest is in Biomedical Research. Dr. Gatanaga, as an author/co-author, has published more than 190 articles in various journals, having a significant number of over 3,295 total citations.
) Department of Outpatient AIDS Clinical Center, International Medical Center of Japan Tokyo Japan
Dr. Homayon Ghiasi, Ph.D., is the Professor and Director of Center of Neurobiology and Vaccine development at Cedars-Sinai Medical Center, Los Angeles, CA, USA. The research interest of Dr. Ghiasi concerns viral pathogenesis and immunology of ocular herpes simplex virus type 1 (HSV-1) infection. The specific areas of studies are the role of HSV-1 in herpes induced corneal scarring, vaccine development against ocular HSV-1 infection, and the role of viral infection and cytokines in CNS demyelination. His further activities/associations include the following: Association for Research in Vision and Ophthalmology, 1987, and American Society for Microbiology, 1985. Dr. Ghiasi, is an author/co-author, has published more than 120 articles in various journals, having a significant number of over 3,945 total citations.
) Center for Neurobiology and Vaccine Development Cedars-Sinai Medical Center Los Angeles, CA USA
Prof. David Harrich obtained his Ph.D. degree in Experimental Pathology from University of California (UCLA), Los Angeles, CA, USA, and he undertook postdoctoral training at University of Texas Southwestern Medical Centre, Dallas, TX, USA. Prof. Harrich is Group Leader of HIV and Molecular Virology at QIMR Berghofer Medical Research Institute Brisbane City, Australia, where he is a Senior Research Fellow. He has authored/co-authored over 70 papers (having a significant number of total citations, i.e. more than 2,590), and most of them involve the areas of HIV-1 molecular biology and virus replication.
) Division of Infectious Diseases Royal Brisbane Hospital Brisbane Australia
Dr. Erich R. Mackow obtained his Ph.D. degree in 1984 from Temple University, Philadelphia, PA, USA. He is a Professor in the Department of Molecular Genetics and Microbiology at Stony Brook University, Stony Brook, NY, USA. Dr. Mackow has made critical contributions to our understanding of molecular mechanisms of viral pathogenesis, and his current studies are focused on understanding Zika, Dengue and Hantavirus regulation of endothelial cell responses that contribute to lethal vascular disease syndromes. Dr. Mackow, as an author/co-author, has published more than 100 articles in various journals, having a significant number of total citations, i.e. over 3,925.
) Departments of Medicine, Molecular Genetics and Microbiology Stony Brook University Stony Brook, NY USA
Professor M. John Albert at the Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait. His area of work is etiology and pathogenesis of enteric microbial infections. He has interest in viral agents causing diarrhea. He has over 300 publications including primary journal articles, reviews and book chapters.
) Department of Microbiology Kuwait University Al-khaldiya Kuwait
Dr. Maria Luisa Calabrò is a senior investigator at the Unit of Immunology and Molecular Oncology, Veneto Institute of Oncology, Padua, Italy. Since 1997, she has studied HHV8 seroprevalence, transmission modalities, in vitro infection systems, preclinical models of HHV8-induced lymphomagenesis, and the role of mesothelial cells and EMT in primary effusion lymphoma pathogenesis. She is presently studying the mechanisms underlying the oncogenic conversion of HTLV-1-immortalized T-cells. Dr. Calabrò, as an author/co-author, has published more than 45 articles in various journals, having total number of citations of over 1,120.
) Dipartimento di Scienze Oncologiche e Chirurgiche Istituto Oncologico Veneto Padua Italy
Doctor Éric A. Cohen is Director of the Laboratory of Human Retrovirology at the Institut de recherches cliniques de Montréal (IRCM). He is also Professor of Virology at the Department of Microbiology, Infectiology and Immunology at the Université de Montréal and recipient of the IRCM-Université de Montréal Chair of Excellence in HIV Research. Dr. Cohen’s research focuses on better understanding HIV-host interactions regulating viral replication, transmission, and persistence. He is author of over 160 articles and books, as well as the holder of several international patents.
Dr. Cohen obtained a B.Sc. in Biochemistry from McGill University and a Ph.D. in Molecular Biology from l’Université de Montréal. He is a fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences and a member of the editorial board of Retrovirology and Current HIV Research. Since 2014, he leads the Canadian HIV Cure Enterprise, a pan-Canadian multidisciplinary research consortium dedicated to HIV cure research.
) Recherche du Canada en Rétrovirologie Humaine Institut de Recherches Cliniques de Montréal Montreal, QC Canada
Dr. Das is Chairman & Hargobind Khorana Chair Professor at Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Noida, India. He has more than 35 years of experience in research, drug discovery and teaching in molecular oncology, tumor virology, human genetics and stem cell biology. He worked several years with Nobel Laureate Harald zur Hausen at DKFZ Heidelberg, Germany. Dr. Das served as Founder Director of ICPO of ICMR and later as Director of ACBR at University of Delhi, India. Dr. Das is a UICC Fellow, served as WHO experts, received several awards and Fellow of all national science and medical academies. He has more than 200 research publications that include Nature, Lancet, 3 patents and guided 36 Ph.D. and 79 MD/MS/DNB/DM students for their degrees.
) Molecular Biology of Cancer, Molecular Virology and Human Molecular Genetics Institute of Cytology and Preventive Oncology (ICMR) Noida India
William Dundon received his primary and PhD degrees from the Microbiology Department, Trinity College Dublin, Ireland. He has over 25 years years of experience in research based activities both in the public and private sectors which have included the OIE/FAO and National Reference Laboratory for Avian influenza (Padova, Italy), Columbia University (New York, USA), Pasteur Institute (Lille, France), and the University of Padova, (Italy). During this time, Dr Dundon’s work has included research on infectious diseases of both human and animal importance such as Avian influenza, Rabies, Newcastle disease, Helicobacter pylori and Poliovirus using molecular biological, epidemiological and diagnostic techniques. He has published over 40 peer-reviewed publications to date. Dr Dundon is currently working as an expert consultant for the Animal Production and Health Laboratory of the FAO/IAEA Joint division focusing primarily on the molecular epidemiology of Peste des Petits Ruminants.
) Division of Nuclear Techniques in Food and Agriculture International Atomic Energy Agency Vienna Austria
Georges Herbein obtained his MD at the Strasbourg Medical School in 1991 and his PhD in Virology at the Oxford University/Strasbourg University in 1993. From 1991-1993, he was an INSERM/ALLIANCE fellow in the Sir William Dunn School of Pathology at the Oxford University From 1993 to 1995. Dr. Herbein was an Assistant Professor at the Department of Clinical Virology at the Strasbourg Medical School Hospital. From 1995 to 1997, he held a staff scientist position at the Picower Institute for Medical Research at Manhasset, New York. From 1997-2001, he was an Assistant Professor in the Department of Internal Medicine, Division of Infectious Diseases, at the University of Texas Medical Branch at Galveston. He is currently a Professor of Virology and the Director of the laboratory Pathogens & Inflammation at the University of Franche-Comté, Besancon, France. Pr. Herbein is currently a member of the editorial board of several scientific journals. He has produced more than 100 peer-reviewed original scientific papers and chapters in learned textbooks. He is the editor of the book HIV and The Macrophage. Prof. Herbein’s research interest is the pathogenesis of viral infections with special emphasis on human immunodeficiency virus, cytomegalovirus, macrophages, and proinflammatory cytokines, especially tumor necrosis factor alpha. Recently, Pr. Herbein has been involved in research on viruses and cancer. He is also the recipient of numerous awards.
) Department of Virology University of Franche-Comte Besancon France
Dr. Kaye is Associate Professor at Harvard Medical School and Associate Physician at Brigham And Women's Hospital. Dr. Kaye’s research investigates the association between viruses and human malignancy. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) has a causative role in Kaposi's sarcoma, primary effusion lymphomas and multicentric Castleman's disease, an aggressive lymphoproliferative disorder. The goal of Dr. Kaye’s work is to gain a better understanding of the molecular mechanisms through which KSHV exerts tumorigenic effects on cells.
) Department of Medicine Harvard Medical School Boston, MA USA
Vaibhav Tiwari received his PhD in Biotechnology from the Banaras Hindu University (India). He is an Associate Professor in the Departments of Microbiology & Immunology at Midwestern University, Illinois. His area of interest include understanding the molecular mechanism of herpes virus entry and associated inflammation. His scientific contribution includes the characterization of heparan sulfate (HS) modifying enzyme 3-O sulfotransferase (3-OST) isoforms for herpes simplex virus (HSV) entry, discovery of a novel phagocytic mode of HSV entry and the generation of peptides using phage display library screening against HS and 3-O sulfated HS (3-OS HS) to develop viral entry inhibitors. In addition, his work further demonstrated the structural-functional similarities between the human and zebrafish for certain 3-OST isoforms in supporting HSV entry and spread. The future goal of Dr. Tiwari’s work is to have better understanding regarding the molecular mechanism by which HS and 3-OS HS supports both viral entry and triggers the inflammatory response to damage host cell.
) Department of Microbiology & Immunology Midwestern University Downers Grove, IL USA
Dr. Arsenakis Minas received his B.Sc. (hons) from La Trobe University (Melbourne Αustralia) in 1978 and Ph.D. from La Trobe University (Melbourne Australia) in 1982. Currently, he is professor of the School of Biology of Aristotle in University of Thessaloniki and director of the laboratory of General Microbiology. He has around 90 scientific publications to his credit. He has received various awards and scholarships for his contributions over the years including Australian Government Postgraduate award, Greek-Australian Society award in the biomedical sciences, Damon Runyon-Walter Winchell Postdoctoral award, and Leukemia Research Foundation Postdoctoral award.
) Laboratory of General Microbiology Aristotle University Thessaloniki Greece
Dr. Udeni Balasuriya obtained his Ph.D. degree (1996) in comparative pathology and molecular virology from the University of California-Davis, Davis, CA, USA. Since 2011, Dr. Balasuriya is Professor of Virology, Department of Veterinary Science, Maxwell H. Gluck Equine Research Center, University of Kentucky, Lexington, KY, USA. His main areas of research interest include immunology, microbiology, pathology, and virology. He, as an author/co-author, has published more than 120 articles in various journals, having a significant number of total citations, i.e. over 2,485.
) Department of Pathobiological Sciences Louisiana State University Baton Rouge USA
Dr. John Burand obtained his M.S. degree from Miami University (Oxford, OH, USA) in 1974, and his Ph.D. degree in Microbiology from Washington State University (Pullman, WA, USA) in 1979. His research areas include the use of viruses as bionanoparticles for the delivery of biologically active materials, including DNA, RNA and proteins. He has authored/co-authored over 55 research items and his major research includes the following: Future in insect management. J Invertebr Pathol, Analysis of the genome of the sexually transmitted insect virus Helicoverpa zea nudivirus 2.Viruses. 4(1):28-61.
) Department of Microbiology University of Massachusetts Amherst, MA USA
Dr. Volker R.M. Daniel obtained his Doctor of Medicine degree (1981) from University of Giessen, Germany, and his Doctorate (honorary) (2003) from University of Pleven, Bulgaria. Since 2000, Dr. Daniel is Professor of Immunology at Heidelberg University, Heidelberg, Germany. He is also Honorary Doctor at Medical University of Pleven, Bulgaria. He is a Member of Transplantation Society, International Acquired Immune Deficiency Syndrome Society (advisor), German Association for Immunology, and New York Academy of Sciences. His skills and expertise lie in the subject areas of Flow Cytometry, Cytokines, T Lymphocytes, Autoantibodies, Lymphocytes, and CD4-Positive T-Lymphocytes. Dr. Daniel, as an author/co-author, has published more than 205 articles in various journals, having a significant number of total citations, i.e. over 3,985.
Dr. Gaetano Donofrio currently works as Associate Professor in the Department of Veterinary Science at University of Parma, Parma, Italy. Dr. Donofrio obtained his Ph.D. degree in Molecular Biology (first year at Parma University - Department of Gene Expression Edinburgh) on a project regarding Ovine-Betalactoglobulin introns splicing and gene expression in mammary gland of transgenic mice. He got a permanent position as Researcher (Assistant Professor) at the Veterinary Medical School of Parma University. Dr. Donofrio, as an author/co-author, has published more than 105 articles in various journals, having a significant number of over 2,225 total citations.
) Dipartimento di Salute Animale University of Parma Parma Italy
Dr. Mark Alan Feitelson obtained his Ph.D. degree (1979) from the School of Medicine, University of California, Los Angeles, CA, USA. Since 2007, he is Professor of Biology, in the Department of Biology, at Temple University, Philadelphia, PA, USA. Since the early 1980's, Dr. Feitelson has been interested in the pathogenesis of chronic hepatitis B virus infection and has uncovered critical steps whereby the HBV encoded X antigen contributes to the pathogenesis of chronic liver disease and the development of HCC. He has also developed a program studying the relationship between the gut microbiome and various disease states. He has authored/co-authored over 130 article publications, having a significant number of total citations, i.e. more than 5,470.
) Department of Biology Temple University Philadelphia, PA USA
Dr. Philippe Georgel, Ph.D., is currently Professor (Full), in the Center for Immunology and Hematology Research, at University of Strasbourg (UNISTRA – INSERM UMR), Strasbourg, France. His skills and expertise mainly lie in the subject areas of Genetics, Microbiology, Inflammation, Immunology, RNA Interference, Signaling Pathways, Cytokines, Macrophage, Immune Response, microRNA, Rheumatoid Arthritis, Toll-Like Receptors, Interferon, and Host-Pathogen Interactions. Dr. Georgel, as an author/co-author, has published more than 65 articles in various journals, having a significant number of total citations, i.e. over 6,350.
) Faculte de Medecine Laboratoire d'ImmunoGenetique Moleculaire Humaine Strasbourg France
Dr. Germain Gillet obtained his Ph.D. degree (1985) in Molecular pharmacology of serotonin receptors from Pasteur Institute, Paris, France. He currently works as Laboratory Head at the Cancer Cells Plasticity, Cancer Research Center of Lyon, France. Dr. Gillet’s skills and expertise mainly lie in the subject areas of Cancer Biology, Cell Signaling, Apoptosis, Cell Proliferation, Signal Transduction, Phosphorylation, Mitochondria, Cell Death, and Bcl-2. He, as an author/co-author, has published over 100 research items with over 1000 total citations.
) Institut de Biologie et Chimie des Protéines Université Claude Bernard Lyon cedex France
Dr. Veijo Hukkanen is currently at the Department of Virology at University of Turku, Finland. Dr. Hukkanen has served as Professor of Virology at the University of Oulu and at the University of Turku. His research has involved herpes simplex virus (HSV) latency and pathogenesis, antiviral therapy and recombinant virus technology. His major area of expertise is Virology, especially herpesviruses, gene therapy vectors (HSV vectors) and viral immunology. Dr. Hukkanen has been the convener and co-chair of the International Herpesvirus meeting in 2005, and has served as a chairperson and SAB member in numerous international virology and gene therapy meetings.
) Department of Virology University of Turku Turku Finland
S.K. Ghosh Cancer Research Center Boston University School of Medicine Boston, MA USA